Conclusion
We performed pharmaceutical care for patients with mild or moderate
COVID-19 at Jianghan Fangcang hospital. A retrospective study was
followed to evaluate the usefulness of Clinical pharmacists at Fangcang
hospitals, which indicate that clinical pharmacist can effectively
reduce and prevent drug-related, life-related and COVID-19-related
problems for COVID-19 patients. This work may reduce the work pressure
of first line medical staffs, provide possible work patterns for
clinical pharmacist in other hospital and give more professional service
for Fangcang hospital patients.
Acknowledgements: The research reported in this publication was
supported by National Key R&D Program of China 2017YFC0909900. Yu Zhang
and Yong Han contributed to the concept and design of this article,
Dongyuan Wang and Yihui Liu helped for the data analysis and wrote this
manuscript, Fang Zeng, Fang Cheng helped for the data collection. Chen
Shi helped for the revision of the article.